Investors are eyeing opportunities to reallocate capital as stocks remain elevated following an 18% surge since March. While many are hesitant, fearing a potential market pullback, a closer inspection reveals several growth stocks that are not overly inflated. Among these are Shopify, Nice Ltd., and Viking Therapeutics, each presenting unique investment propositions.
Shopify (SHOP) has seen its stock drop 40% from its October peak, driven by concerns over sales growth and rising interest rates. However, its recent revenue growth of 34% in Q1 suggests resilience, positioning it as a key player in the evolving e-commerce landscape. Nice Ltd. (NICE), a leader in customer service technology, has experienced a 65% decline from its peak, despite strong recurring revenue growth, thanks in part to its acquisition of AI software specialist Cognigy. Viking Therapeutics (VKTX) is making strides in the competitive weight-loss drug market with its promising dual agonist, VK2735, currently in phase 3 trials.
For market professionals, these stocks present potential entry points amid broader market caution. With solid fundamentals and growth prospects, they may offer attractive risk-adjusted returns as conditions stabilize.
Source: fool.com